Latest
Featured Content
Hematopoietic Stem Cell Transplantation
Can Modifying Microbial Diversity Change Outcomes Following Allogeneic HSCT?
Some studies have found a link between intestinal microbiota composition and development of acute graft-versus-host disease.
ASH 2018
Expert Perspective: The Role of Ibrutinib and Venetoclax in Chronic Lymphocytic Leukemia
Hematology Advisor asked Prithviraj Bose, MD, to discuss the latest research on treatment options for CLL presented at the ASH 2018 Annual Meeting.
Thrombotic Disorders
Updated Clinical Practice Guidelines for Venous Thromboembolism: Pregnant and Pediatric Patients
In this 3-part series, Hematology Advisor spoke with experts about the revisions to the ASH clinical practice guidelines for venous thromboembolism.
Lymphoma
Researchers Report Early Clinical Promise for Macrophage Checkpoint Blockade
A doublet immunotherapy regimen incorporating the investigational mAb Hu5F9-G4 shows clinical activity in patients with relapsed/refractory non-Hodgkin lymphoma.
Thrombotic Disorders
Updated Clinical Practice Guidelines for Venous Thromboembolism: Treatment Strategies
In this 3-part series, Hematology Advisor spoke with experts about the revisions to the ASH clinical practice guidelines for venous thromboembolism.
